Dr. Debasis Hazra
Chief Scientist22+ years of experience leading API development for NCEs and generic programs across global markets. Recognized for developing the commercial process for Umbralisib (UKONIQ), a landmark USFDA-approved NCE from India.
- Expert in route design, process optimization, and scale-up from early development through commercial manufacturing.
- Held key roles at AstraZeneca, Pharmaron, Alembic Pharmaceuticals, and Cadila Pharmaceuticals.
- Extensive advanced research experience across premier international institutions, including NCL (National Chemical Laboratory), Pune; University of Hawaii, USA; and Purdue University, Indiana, USA.
- Ph.D. from Savitribai Phule Pune University and M.S. from the University of Burdwan.